These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37215087)

  • 81. Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation.
    Pipatwatcharadate C; Iyer PR; Pissuwan D
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896242
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize.
    Giuliano M; Shaikh A; Lo HC; Arpino G; De Placido S; Zhang XH; Cristofanilli M; Schiff R; Trivedi MV
    Cancer Res; 2018 Feb; 78(4):845-852. PubMed ID: 29437766
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
    De Souza LM; Robertson BM; Robertson GP
    Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Complexities of Metastasis.
    San Juan BP; Garcia-Leon MJ; Rangel L; Goetz JG; Chaffer CL
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623163
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Metastasis: new functional implications of platelets and megakaryocytes.
    Leblanc R; Peyruchaud O
    Blood; 2016 Jul; 128(1):24-31. PubMed ID: 27154188
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
    Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation.
    Pantel K; Alix-Panabières C
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36517082
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
    Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model.
    Zhang L; Zhu Y; Wei X; Chen X; Li Y; Zhu Y; Xia J; Huang Y; Huang Y; Wang J; Pang Z
    Acta Pharm Sin B; 2022 Aug; 12(8):3427-3447. PubMed ID: 35967283
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fibrinolytic Platelet Decoys Reduce Cancer Metastasis by Dissociating Circulating Tumor Cell Clusters.
    Schnoor B; Morris K; Kottana RK; Muldoon R; Barron J; Papa AL
    Adv Healthc Mater; 2024 Oct; 13(26):e2304374. PubMed ID: 39075814
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Crosstalk between Circulating Tumor Cells and Plasma Proteins-Impact on Coagulation and Anticoagulation.
    Wang Y; Schneider SW; Gorzelanny C
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296987
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer.
    Lim M; Park S; Jeong HO; Park SH; Kumar S; Jang A; Lee S; Kim DU; Cho YK
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771436
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Circulating cancer stem cells: the importance to select.
    Yang MH; Imrali A; Heeschen C
    Chin J Cancer Res; 2015 Oct; 27(5):437-49. PubMed ID: 26543330
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease.
    Hanssen A; Riebensahm C; Mohme M; Joosse SA; Velthaus JL; Berger LA; Bernreuther C; Glatzel M; Loges S; Lamszus K; Westphal M; Riethdorf S; Pantel K; Wikman H
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30572662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.
    Wallwiener M; Hartkopf AD; Riethdorf S; Nees J; Sprick MR; Schönfisch B; Taran FA; Heil J; Sohn C; Pantel K; Trumpp A; Schneeweiss A
    BMC Cancer; 2015 May; 15():403. PubMed ID: 25972110
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Simulating the Effect of Removing Circulating Tumor Cells (CTCs) from Blood Reveals That Only Implantable Devices Can Significantly Reduce Metastatic Burden of Patients.
    Baumgartner W; Aceto N; Lifka S
    Cancers (Basel); 2024 Sep; 16(17):. PubMed ID: 39272936
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Visualizing cancer extravasation: from mechanistic studies to drug development.
    Cheng X; Cheng K
    Cancer Metastasis Rev; 2021 Mar; 40(1):71-88. PubMed ID: 33156478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.